Hims & Hers Health (NYSE: HIMS) Faces Securities Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower -- HBSS

Hagens Berman announced a securities class action against Hims & Hers Health and certain executives, soliciting investors with losses to submit claims before a Nov. 2, 2026 lead plaintiff deadline. The suit follows a July 29, 2026 FTC federal complaint -- joined by Utah and Los Angeles County -- alleging deceptive sharing of consumer health data with Meta and Snap, plus ROSCA violations around subscription billing and cancellation barriers. The underlying regulatory action drove HIMS shares down $4.32 (-14.7%), erasing over $970 million of market cap in one day; the class period runs Aug.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.